142 related articles for article (PubMed ID: 37563079)
1. Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort.
Fernandez HH; Odin P; Standaert DG; Henriksen T; Jimenez-Shahed J; Metz S; Alobaidi A; Yan CH; Kukreja P; Parra JC; Zamudio J; Onuk K; Wright J; Antonini A
Parkinsonism Relat Disord; 2023 Nov; 116():105514. PubMed ID: 37563079
[TBL] [Abstract][Full Text] [Related]
2. Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 Countries.
Antonini A; Pahwa R; Odin P; Henriksen T; Soileau MJ; Rodriguez-Cruz R; Isaacson SH; Merola A; Lindvall S; Domingos J; Alobaidi A; Jalundhwala YJ; Kandukuri PL; Parra JC; Kukreja PK; Onuk K; Bergmann L; Pike J; Ray Chaudhuri K
Neurol Ther; 2022 Mar; 11(1):303-318. PubMed ID: 35015215
[TBL] [Abstract][Full Text] [Related]
3. Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries.
Malaty IA; Martinez-Martin P; Chaudhuri KR; Odin P; Skorvanek M; Jimenez-Shahed J; Soileau MJ; Lindvall S; Domingos J; Jones S; Alobaidi A; Jalundhwala YJ; Kandukuri PL; Onuk K; Bergmann L; Femia S; Lee MY; Wright J; Antonini A
BMC Neurol; 2022 Jan; 22(1):35. PubMed ID: 35073872
[TBL] [Abstract][Full Text] [Related]
4. Real-world assessment of "OFF" episode-related healthcare resource utilization among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
J Med Econ; 2021; 24(1):540-549. PubMed ID: 33819121
[TBL] [Abstract][Full Text] [Related]
5. Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach.
Macchi ZA; Koljack CE; Miyasaki JM; Katz M; Galifianakis N; Prizer LP; Sillau SH; Kluger BM
Ann Palliat Med; 2020 Feb; 9(Suppl 1):S24-S33. PubMed ID: 31735048
[TBL] [Abstract][Full Text] [Related]
6. Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
Pålhagen SE; Sydow O; Johansson A; Nyholm D; Holmberg B; Widner H; Dizdar N; Linder J; Hauge T; Jansson R; Bergmann L; Kjellander S; Marshall TS
Parkinsonism Relat Disord; 2016 Aug; 29():17-23. PubMed ID: 27318707
[TBL] [Abstract][Full Text] [Related]
7. Impact of advanced Parkinson's disease on caregivers: an international real-world study.
Martinez-Martin P; Skorvanek M; Henriksen T; Lindvall S; Domingos J; Alobaidi A; Kandukuri PL; Chaudhari VS; Patel AB; Parra JC; Pike J; Antonini A
J Neurol; 2023 Apr; 270(4):2162-2173. PubMed ID: 36633671
[TBL] [Abstract][Full Text] [Related]
8. The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's Disease.
Pigott JS; Bloem BR; Lorenzl S; Meissner WG; Odin P; Ferreira JJ; Dodel R; Schrag A
J Geriatr Psychiatry Neurol; 2024 Jan; ():8919887231225484. PubMed ID: 38230692
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial.
Radder DLM; Lennaerts HH; Vermeulen H; van Asseldonk T; Delnooz CCS; Hagen RH; Munneke M; Bloem BR; de Vries NM
Trials; 2020 Jan; 21(1):88. PubMed ID: 31941538
[TBL] [Abstract][Full Text] [Related]
10. Association of Caregiver Depression Risk With Patient Outcomes in Parkinson Disease.
Rashid R; Aamodt WW; Horn S; Dahodwala N
JAMA Netw Open; 2023 Aug; 6(8):e2327485. PubMed ID: 37566420
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
Antonini A; Pahwa R; Odin P; Isaacson SH; Merola A; Wang L; Kandukuri PL; Alobaidi A; Yan CH; Bao Y; Zadikoff C; Parra JC; Bergmann L; Chaudhuri KR
CNS Drugs; 2022 Dec; 36(12):1269-1283. PubMed ID: 36414908
[TBL] [Abstract][Full Text] [Related]
12. Caregiver burden in Parkinson's disease: a mixed-methods study.
Geerlings AD; Kapelle WM; Sederel CJ; Tenison E; Wijngaards-Berenbroek H; Meinders MJ; Munneke M; Ben-Shlomo Y; Bloem BR; Darweesh SKL
BMC Med; 2023 Jul; 21(1):247. PubMed ID: 37424022
[TBL] [Abstract][Full Text] [Related]
13. Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study.
Tessitore A; Marano P; Modugno N; Pontieri FE; Tambasco N; Canesi M; Latorre A; Lopiano L; Sensi M; Quatrale R; Solla P; Defazio G; Melzi G; Costanzo AM; Gualberti G; di Luzio Paparatti U; Antonini A
J Neurol; 2018 May; 265(5):1124-1137. PubMed ID: 29516169
[TBL] [Abstract][Full Text] [Related]
14. [Advanced Parkinson's disease characteristics in clinical practice: Results from the OBSERVE-PD study and sub-analysis of the Hungarian data].
Takáts A; Aschermann Z; Vécsei L; Klivényi P; Dézsi L; Zádori D; Valikovics A; Varannai L; Onuk K; Kinczel B; Kovács N
Ideggyogy Sz; 2020 Jul; 73(7-08):261-268. PubMed ID: 32750243
[TBL] [Abstract][Full Text] [Related]
15. Economic and health-related quality of life considerations of new therapies in Parkinson's disease.
Rubenstein LM; DeLeo A; Chrischilles EA
Pharmacoeconomics; 2001; 19(7):729-52. PubMed ID: 11548910
[TBL] [Abstract][Full Text] [Related]
16. Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines.
Kulisevsky J; Falup-Pecurariu C; Santens P; Jost WH
J Neural Transm (Vienna); 2023 Nov; 130(11):1433-1441. PubMed ID: 37439943
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson's Disease.
Thaler A; Barer Y; Gross R; Cohen R; Bergmann L; Jalundhwala YJ; Giladi N; Chodick G; Shalev V; Gurevich T
Adv Ther; 2022 May; 39(5):2009-2024. PubMed ID: 35247187
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Patient-Reported and Caregiver-Reported Swallowing-Related Quality of Life in Parkinson's Disease.
Zimmerman AS; Shune S; Smith KG; Estis JM; Garand KL
Dysphagia; 2022 Apr; 37(2):436-445. PubMed ID: 33846834
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis.
Li T; Zou S; Zhang Z; Liu M; Liang Z
BMC Neurol; 2022 Aug; 22(1):320. PubMed ID: 36008796
[TBL] [Abstract][Full Text] [Related]
20. The Parkinson's Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson's Disease in Patients and their Carers.
Tolosa E; Ebersbach G; Ferreira JJ; Rascol O; Antonini A; Foltynie T; Gibson R; Magalhaes D; Rocha JF; Lees A
J Parkinsons Dis; 2021; 11(3):1309-1323. PubMed ID: 34024784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
